NASDAQ:ASBP

Aspire Biopharma (ASBP) Stock Price, News & Analysis

Aspire Biopharma logo
$7.89 -0.41 (-4.94%)
Closing price 11/18/2026 03:59 PM Eastern
Extended Trading
$8.12 +0.23 (+2.97%)
As of 11/18/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aspire Biopharma Stock (NASDAQ:ASBP)

Advanced

Key Stats

Today's Range
$7.89
▼
$8.70
50-Day Range
$6.76
▼
$9.12
52-Week Range
$3.31
▼
$205.20
Volume
7,986 shs
Average Volume
21,719 shs
Market Capitalization
$11.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Aspire Biopharma is a biopharmaceutical company developing drug products that use sublingual delivery, in which a medicine is placed under the tongue for absorption. Its platform is intended to create rapidly absorbed formulations of existing drugs.

The company has highlighted sublingual formulations based on aspirin and caffeine among its product candidates. These are under development; Aspire’s focus is on developing potential therapies rather than marketing an established portfolio of approved products.

AI Generated. May Contain Errors.

Aspire Biopharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

ASBP MarketRank™: 
0.85 of 5 stars

Aspire Biopharma scored higher than 17% of companies evaluated by MarketBeat, and ranked 887th out of 938 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aspire Biopharma has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Aspire Biopharma has only been the subject of 1 research reports in the past 90 days.

  • Read more about Aspire Biopharma's stock forecast and price target.
    • Percentage of Shares Shorted

      0.45% of the float of Aspire Biopharma has been sold short.
    • Short Interest Ratio / Days to Cover

      Aspire Biopharma has a short interest ratio ("days to cover") of 0.24, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Aspire Biopharma has recently decreased by 32.21%, indicating that investor sentiment is improving significantly.
    • Dividend Yield

      Aspire Biopharma does not currently pay a dividend.

    • Dividend Growth

      Aspire Biopharma does not have a long track record of dividend growth.

    • News Sentiment

      Aspire Biopharma has a news sentiment score of -0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Consumer Discretionary companies.
    • News Coverage This Week

      MarketBeat has tracked 1 news article for Aspire Biopharma this week, compared to 2 articles on an average week.
    • Insider Buying vs. Insider Selling

      In the past three months, Aspire Biopharma insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      5.80% of the stock of Aspire Biopharma is held by insiders.

    • Percentage Held by Institutions

      19.17% of the stock of Aspire Biopharma is held by institutions.

    • Read more about Aspire Biopharma's insider trading history.
    Receive ASBP Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Aspire Biopharma and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    ASBP Stock News Headlines

    Aspire Biopharma Reports Delay in Quarterly Filing
    Top Trader Reveals Stunning Black Friday Deal
    Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
    Aspire Biopharma Holdings Inc ASBP
    See More Headlines

    ASBP Stock Analysis - Frequently Asked Questions

    Aspire Biopharma's stock was trading at $158.28 at the beginning of the year. Since then, ASBP stock has decreased by 95.0% and is now trading at $7.89.

    Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) issued its earnings results on Friday, November, 14th. The company reported ($48.00) EPS for the quarter. The firm had revenue of $1.94 thousand for the quarter.

    Aspire Biopharma shares reverse split before market open on Monday, May 11th 2026.The 1-30 reverse split was announced on Thursday, May 7th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

    Shares of ASBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Company Calendar

    Today
    11/18/2026
    Fiscal Year End
    12/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Automobile Components
    Sub-Industry
    Automotive Parts & Equipment
    Current Symbol
    NASDAQ:ASBP
    Previous Symbol
    NASDAQ:PWUP
    CIK
    1847345
    Fax
    N/A
    Employees
    2
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    ($69.62)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$24.48 million
    Net Margins
    -11,362.21%
    Pretax Margin
    -11,361.18%
    Return on Equity
    N/A
    Return on Assets
    -177.59%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    7.99
    Quick Ratio
    7.82

    Sales & Book Value

    Annual Sales
    $10 thousand
    Price / Sales
    1,104.60
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($54.19) per share
    Price / Book
    -0.15

    Miscellaneous

    Outstanding Shares
    1,400,000
    Free Float
    1,322,000
    Market Cap
    $11.05 million
    Optionable
    N/A
    Beta
    0.17
    Don't Wait for the OpenAI IPO Cover

    The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

    Get This Free Report

    This page (NASDAQ:ASBP) was last updated on 11/18/2026 by MarketBeat.com Staff.
    From Our Partners